ESMO Congress 2021 Satellite Symposia | Virtual Congress | Novartis HCP

This site is for health care professionals only.

.atomic-select.jsAtomicSelect { display: none; }

.atomic-navigation-links__li._lvl1:hover .atomic-navigation-links__ul._lvl2 { display: block; } .atomic-navigation-links__li._lvl1:hover .atomic-navigation-links__plus-expand-icon { display: none; } .atomic-navigation-links__li._lvl1:hover .atomic-navigation-links__minus-expand-icon { display: block; }

Our 4 Bold Approaches to Cancer Treatment

Novartis Satellite Symposia at the Virtual ESMO Congress 2021

Unmet Needs in Oncogene-Driven NSCLC: How Do We Close the Gap?

September 17, 2021 | 10:30 - 12:00 CEST | Channel 6

Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future

September 18, 2021 | 8:45 - 10:15 CEST | Channel 5

Improving Survival Outcomes in HR+/HER2− Advanced Breast Cancer: A Biological Perspective

September 19, 2021 | 10:30 - 12:00 CEST | Channel 3

Cutting through the noise: How Do GEP-NET Patients Stand to Benefit From PRRT?

September 20, 2021 | 8:45 - 10:15 CEST | Channel 6

Actionable Targets in Advanced Prostate Cancer: The Potential of Molecular Profiling and Radioligand Therapy

September 20, 2021 | 10:30 - 12:00 CEST | Channel 6

Staying on Track: Translating Evidence to Practice in Melanoma

September 20, 2021 | 10:30 - 12:00 CEST | Channel 4

.lazy { display: none; }

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2021 Novartis AG. All rights reserved.

9/21 148216